NGS-based RNA-seq Market Surveying Report, Drivers, Scope and Regional Analysis by 2021-2031

NGS-based RNA-seq Market Research Report efficiently gathers information about target markets or customers. It consists of qualitative including focus groups, in-depth interviews as well as quantitative techniques that include customer survey and analysis of secondary data. Market report aids in planning business by providing information about the market. Up-to-date marketing reports help companies to have in depth analysis of industry and future trends. In this NGS-based RNA-seq market report, data collection modules with large sample sizes are used to collect data and perform base year analysis. The market drivers and restraints have been explained in the report using SWOT analysis.

Get a Sample PDF of the report @: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=58671&utm_source=Openpr_Amit&utm_medium=Openpr

Major Players in This Report Include: Illumina, Inc., Roche Holding AG, QIAGEN N. V., Thermo Fisher Scientific Inc., PerkinElmer, Inc., BGI, Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., Agilent Technologies, Inc., Macrogen, Inc., GATC Beq market, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ, Inc., Hamilton Company, Zymo Research, Tecan Genomics, Inc., Others

Introduction of next-generation sequencing technology has increased demand for NGS-based RNA-seq across the globe. NGS-based RNA-seq is largely used in both conventional and non-conventional applications to get advanced and comprehensive insights at a genomic level. Rise in need of advanced sequencing-based diagnostics has created a demand for new seq-technologies. Therefore, demand for devices such as high-throughput sequencers and portable units has increased substantially. The demand for NGS-based RNA-seq is rising due to various factors including technological advancements in RNA-seq products, benefits of RNA-seq compared to microarray technology, rapid growth in research activities, increase in grants for RNA-seq, and significant demand for precision medicine.

Key Drivers, Restraints, and Opportunities of Global NGS-based RNA-seq Market

Adoption of next generation sequencing has increased in the past few years due to decline in cost. For example, the first human genome sequencing cost around US$ 3 Bn in 2001 and it took around 15 years for completion. Presently, the cost of the same is around US$ 1,000 and the process requires less number of days. The cost of sequencing was around US$ 3 Bn, which dropped to US$ 10 million in 2006. Technological developments reduced the cost to US$ 5,000 in 2016. Market players such as Illumina, Inc. and Roche have introduced breakthrough sequencing technologies that have led to cost and time reduction. Moreover, the number of service providers has increased and these are delivering next generation sequencing at lower cost.

Advancements in the field of molecular biology has enhanced the sequencing procedures. Most of the industry players have come up with innovative NGS technology in the past few years such as Sequel (Pacific Biosciences) and PromethION (Oxford Nanopore). Additionally, three advanced NSG systems that lead the market are Roche GS FLX (454), Illumina HiSeq 2000 (Solexa), and AB SOLiD (Agencourt).

Global NGS-based RNA-seq Market: Research Scope

Global NGS-based RNA-seq Market, by Product
• Sequencing Platforms & Consumables
• Sample Preparation Products
• Sequencing Services
• Data Analysis, Storage, and Management

Global NGS-based RNA-seq Market, by Technology
• Ion Semiconductor Sequencing
• Sequencing by Synthesis
• Single-molecule Real-time Sequencing
• Nanopore Sequencing

Global NGS-based RNA-seq Market, by Application
• Small RNA Sequencing
• Expression Profiling Analysis
• Variant Calling & Transcriptome Epigenetics
• De Novo Transcriptome Assembly

Global NGS-based RNA-seq Market, by End-user
• Hospitals & Clinics
• Research & Academia
• Pharmaceutical & Biotechnology Companies
• Others

Report Highlights:
• Comprehensive overview of parent market & substitute market
• In-depth market segmentation (Trends, Growth with Historical & Forecast Analysis)
• Recent industry trends and development activity
• Competitive landscape (Heat Map Analysis for Emerging Players & Market Share Analysis for Major Players along with detailed Profiles)

About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.